Pacira Pharmaceuticals buy HC Wainwright
Start price
08.05.24
/
50%
€26.80
Target price
08.05.25
€53.04
Performance (%)
5.22%
Price
04.06.24
€27.80
Summary
This prediction is currently active. With a performance of 5.22%, the BUY prediction by HC_Wainwright for Pacira Pharmaceuticals is trending in the right direction. This prediction currently runs until 08.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 0.000% |
iShares Core DAX® | -1.042% |
iShares Nasdaq 100 | -1.361% |
iShares Nikkei 225® | -0.044% |
iShares S&P 500 | -0.480% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
5.34%
04.06.24
04.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-0.70%
04.06.24
04.06.24